5470-17-7

Usage

Uses

Used in Pharmaceutical Industry:
2-Chloro-3-bromo-5-nitropyridine is used as an intermediate in the synthesis of antineoplastic and antitumor agents. Its unique chemical structure allows for the development of various compounds with potential therapeutic effects against cancer.
Used in Agrochemical Industry:
2-Chloro-3-bromo-5-nitropyridine is used as a building block in the production of herbicides and insecticides. Its versatility in chemical reactions enables the creation of effective compounds for controlling pests and unwanted plant growth in agricultural settings.
Used in Organic Synthesis:
2-Chloro-3-bromo-5-nitropyridine is used as a versatile building block in organic synthesis. Its ability to undergo various chemical reactions makes it a valuable component in the development of new compounds for a wide range of applications, including pharmaceuticals, agrochemicals, and other industries.

InChI:InChI=1/C5H2BrClN2O2/c6-4-1-3(9(10)11)2-8-5(4)7/h1-2H

Upstream product

• 15862-33-6 3-bromo-2-hydroxy-5-nitropyridine 
• 5418-51-9 5-nitro-2-hydroxypyridine 

Downstream Products

• 15862-50-7 3-bromo-2-methoxy-5-nitropyridine 
• 16098-21-8 3-bromo-1-methyl-5-nitropyridin-2(1H)-one 
• 130284-53-6 5-amino-3-bromo-2-chloropyridine 
• 186593-42-0 3-bromo-2-methyl-5-nitropyridine 
• 1445994-18-2 6-methyl-4-(5-nitro-2-phenoxypyridin-3-yl)-1-tosyl-1H-pyrrolo[2,3-c]pyridin-7(6H)-one 
• 15862-49-4 3-bromo-5-nitro-2-phenoxypyridine 
• 1299312-99-4 N-formyl-4-chloro-2-({2,5-dimethoxypyrid-3-yl}carbonyl)aniline 
• 1299312-98-3 4-chloro-2-({2,5-dimethoxypyrid-3-yl}carbonyl)aniline 
• 1299312-97-2 5-bromo-6-methoxypyridin-3-ol 
• 1093951-75-7 3-bromo-2,5-dimethoxypyridine 
• 1372606-89-7 5-(4-chloro-phenyl)-6-(2, 2, 2-trifluoro-ethoxy)-pyridin-3-ylamine 
• 1372605-60-1 N-(5-(4-chloro-3-methylphenyl)-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-nicotinamide 
• 1372605-58-7 N-(5-(3,4-dimethylphenyl)-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-nicotinamide 
• 1372604-76-6 pentanoic acid[5-(4-chloro-phenyl)-6-(2,2,2-trifluoro-ethoxy)-pyridin-3-yl]-amide 

Relevant academic research and scientific papers

A 2-amino-thiazole compounds (by machine translation)

The present invention relates to the technical field of pharmaceutical chemistry, particularly relates to a 2-amino thiazole compound or its pharmaceutically acceptable salts, its preparation method, and pharmaceutical compositions containing such compounds and its application in the preparation of antineoplastic. (by machine translation)

DYE COMPOSITION COMPRISING A 1,2,3,4-TETRAHYDROPYRIDO[2,3-B]PYRAZIN-7-AMINE COMPOUND

The invention relates to a 1,2,3,4-tetrahydropyrido[2,3-b]pyrazin-7-amine compound of formula (I) below, addition salts thereof, optical isomers, geometrical isomers and tautomersthereof and/or solvates thereof: in which: ?R2, R3, R4, R5, and R7 independently represent: a hydrogen or halogen atom; a C1-C4 alkyl radical; a C1-C4 hydroxyalkyl radical; a carboxyl radical; a (C1-C4)alkoxycarbonyl radical; ? R1 and R6, which may be identical or different, represent: hydrogen atom; C1-C10 and preferably Ci-C6 alkyl radical, - optionally interrupted with one or more heteroatoms chosen from O and S or with one or more groups -NR and/or - optionally terminating with at least one group -NX1X2 or at least one group -OX3, ? X1 and X2 independently denote - a hydrogen atom, a linear C1-C6 alkyl radical, a branched C3-C6 alkyl radical, a linear C1-C6 hydroxyalkyl radical or a branched C3-C6 hydroxyalkyl radical, X1 and X2 may form, with the nitrogen atom that bears them, a saturated or unsaturated 5- to 8-membered heterocycle, in which one of the ring members may be a heteroatom chosen from O, S and N; the said heterocycle possibly being substituted with one or more linear or branched C1-C4 alkyl or C1-C4 hydroxyalkyl radicals, ? X3 denotes - a hydrogen atom - a linear C1-C4 or branched C3-C4 alkyl radical, and ? R denotes - a hydrogen atom - a linear C1-C4 alkyl radical.

Amino substituted aryloxybenzylpiperidine derivatives

This invention is directed to Amino substituted Aryloxybenzylpiperidine derivatives which are ligands at the MCH1 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from obesity which comprises administering to the subject an amount of a compound of the subject invention.

Arylthiobenzylpiperidine derivatives

This invention is directed to Arylthiobenzylpiperidine derivatives which are ligands at the MCH1 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from obesity which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention.

Amino substituted aryloxybenzylpiperidine derivatives

This invention is directed to Amino substituted Aryloxybenzylpiperidine derivatives which are ligands at the MCH1 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from obesity which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention.

Arylthiobenzylpiperidine derivatives

This invention is directed to Arylthiobenzylpiperidine derivatives which are ligands at the MCH1 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from obesity which comprises administering to the subject an amount of a compound of the subject invention.